Pancreatic cancer orthotopic graft in a murine model

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers with increasing incidence. Even if progress have been made, the five-year overall survival remains lower than 10%. There is a desperate need in therapeutic improvements. In the last two decades, new in-vitro models have...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzzolini, Milena, Belhabib, Ismahane, Cardot, Victoire, Tijeras-Raballand, Annemilaï, Neuzillet, Cindy, Bousquet, Corinne, Lupinacci, Renato Micelli, Jean, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403245/
https://www.ncbi.nlm.nih.gov/pubmed/37556720
http://dx.doi.org/10.1590/acb382823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403245/
https://www.ncbi.nlm.nih.gov/pubmed/37556720
http://dx.doi.org/10.1590/acb382823

Ejemplares similares